Primary tumors tend to have higher rates of PD-L1 expression compared to metastatic disease, especially in the liver, skin and bones whilst for lung and lymph nodes metastases, PD-L1 expression is comparable to that of the primary site of tumor (Szekely et al., 2018; Rozenblit et al., 2020). This evidence concerns the gene CD274 and neoplasm.